If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Exercise of Options and Director Dealing

6 Dec 2018 07:00

RNS Number : 5599J
Surface Transforms PLC
06 December 2018
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Surface Transforms plc

 

("Surface Transforms" or the "Company")

 

Exercise of Options and Director Dealing

 

Surface Transforms plc (AIM: SCE) announces that the Company was notified on 5 December 2018 that Dr Kevin Johnson (CEO of Surface Transforms Plc) exercised options over 675,000 ordinary shares of 1p each in the Company ("Ordinary Shares").

 

Specifically, on 5 December 2018, Dr Kevin Johnson purchased 345,000 Ordinary Shares at a price of 9p per Ordinary Share and purchased 330,000 Ordinary Shares at a price of 11.5p.

 

Following the above transactions, Dr Johnson will be beneficially interested in 799,000 Ordinary Shares, which equates to approximately 0.6 per cent. of the Company's total issued share capital.

 

Dr Johnson has advised that he intends to transfer all of these shares to his SIPP but this will not change his beneficial interest in the Company.

 

Admission and Total Voting Rights

 

The new Ordinary Shares will, when issued, rank pari passu in all respects with the existing Ordinary Shares of the Company. Application will be made for the 675,000 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence at 8.00 a.m. on 11 December 2018. Following Admission, the total number of voting rights in the Company will be 123,710,416 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

- Ends -

 

 

 

For enquiries, please contact:

Surface Transforms plc

 

 

Kevin Johnson, CEO

Michael Cunningham CFO

 

+44 151 356 2141

+44 151 348 8882

David Bundred, Chairman

+44 7785 388 848

 

Cantor Fitzgerald Europe (Nomad & Joint-Broker)

+44 20 7894 7000

David Foreman, Richard Salmond, Michael Boot (Corporate Finance)

Caspar Shand Kydd, Gregor Paterson (Sales)

 

 

 

FinnCap Ltd (Joint-Broker)

+44 20 7220 0500

Richard Chambers (Corporate Broking)

Ed Frisby / Giles Rolls (Corporate Finance)

 

 

 

For further Company details, visit www.surfacetransforms.com.

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transaction as described above.

 

 

 

 

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities ("PDMR") and persons closely associated with them ("PCA")

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Dr Kevin Johnson

2

Reason for notification

 

 

 

a.

Position/Status

PDMR

CEO

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Surface Transforms plc

b.

LEI

213800GQHNJPE5O8XO79

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 1p each 

ISIN: GB0002892528

b.

Nature of the transaction

Purchase of 675,000 ordinary shares of 1p each in the Company ("Ordinary Shares).

 

c.

Price(s) and volume(s)

- Transaction 1 (Purchase)

 

- Transaction 2

(purchase)

 

Price(s)

Volume(s)

9.00p

345,000

11.5p

330,000

 

d.

Aggregated information

- Transaction 1

(purchase)

 

- Transaction 2

(purchase)

Price(s)

Aggregated volume(s)

Aggregated Total

9p

345,000

£31,050.00

11.5p

330,000

£37,950.00

 

e.

Date of the transaction

5/12/2018

f.

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGGPCPUPRGWA
Date   Source Headline
29th Feb 20129:30 amRNSDirector/PDMR Shareholding
21st Feb 201210:04 amRNSGrant of Share Options
31st Jan 20127:00 amRNSHalf Yearly Report
25th Jan 201211:15 amRNSNew Distribution Agreement
23rd Jan 20123:45 pmRNSIssue of Options
15th Nov 201110:35 amRNSDirector Shareholding
4th Nov 201110:37 amRNSHolding(s) in Company
21st Oct 201111:30 amRNSDirector/PDMR Shareholding
19th Oct 20117:00 amRNSHolding(s) in Company
17th Oct 20117:00 amRNSResult of AGM and Directorate Changes
8th Aug 20112:35 pmRNSDirector/PDMR Shareholding
5th Aug 20117:01 amRNSDirectorate Change
5th Aug 20117:00 amRNSFinal Results and Notice of Annual General Meeting
16th Jun 20117:00 amRNSPre Close Trading Statement
3rd Mar 20117:00 amRNSSurface Transforms signs Distribution Agreement
24th Feb 20117:00 amRNSHalf Yearly Financial Results
7th Feb 201112:40 pmRNSNotice of Half Yearly Report - replacement
7th Feb 201111:54 amRNSHalf Yearly Report
25th Nov 20102:00 pmRNSResult of EGM and of the Placing and Open Offer
3rd Nov 20107:00 amRNSShareholder Circular of Placing and Open Offer
5th Oct 20107:00 amRNSNew Development Agreement
29th Sep 201011:04 amRNSResult of AGM
16th Aug 20107:00 amRNSFinal Results & Notice of AGM
3rd Jun 20107:00 amRNSDRAFT PRE CLOSE TRADING STATEMENT
9th Mar 20107:00 amRNSDirector/PDMR Shareholding
2nd Mar 201010:00 amRNSGrant of share options
2nd Mar 20107:00 amRNSDirector/PDMR Shareholding
25th Feb 20103:06 pmRNSHolding(s) in Company
24th Feb 20107:00 amRNSHalf-Yearly Results
8th Dec 20097:00 amRNSPlacing
13th Oct 20097:00 amRNSCollaborative R&D project
30th Sep 200910:31 amRNSAppointment of Non Executive Director
29th Sep 20094:02 pmRNSResult of AGM
18th Aug 20097:00 amRNSAnnual Results
17th Aug 200911:59 amRNSHoldings in Company / TVR
12th Aug 20091:16 pmRNSResult of EGM
30th Jul 20097:00 amRNSNew Contract
20th Jul 20097:00 amRNSPlacing
10th Jun 20094:30 pmRNSPre-close Trading Statement - Replacement
10th Jun 200911:40 amRNSPre-close Trading Statement
28th May 200912:08 pmRNSChange of Adviser
26th May 20093:31 pmPRNHolding(s) in Company
9th Apr 20093:05 pmPRNHolding(s) in Company
30th Mar 20094:34 pmPRNHolding(s) in Company
17th Mar 20092:59 pmPRNHolding(s) in Company
26th Feb 20093:09 pmPRNHolding(s) in Company
11th Feb 20097:00 amPRNHalf-yearly Report
7th Jan 200912:56 pmPRNHolding(s) in Company
11th Dec 20087:00 amPRNNew Orders in the Defence Sector
8th Dec 20087:00 amPRNTrading Update and Board Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.